A rebuttal to Akabayashi and colleagues’ criticisms of the iPSC stock project

In the October edition of the Journal of Medical Ethics, Akabayashi and colleagues state that ’to establish a heterogeneous [induced pluripotent stem cell] iPSC bank covering roughly 80% of Japan’s population…the Japanese government decided to invest JPY110 billion (US$ 1.1 billion) over 10 years in...

Full description

Saved in:  
Bibliographic Details
Authors: Fujita, Misao (Author) ; Tabuchi, Keiichi (Author)
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 2019
In: Journal of medical ethics
Year: 2019, Volume: 45, Issue: 7, Pages: 476-477
Online Access: Volltext (kostenfrei)
Volltext (kostenfrei)

MARC

LEADER 00000caa a22000002 4500
001 1816160458
003 DE-627
005 20230428063518.0
007 cr uuu---uuuuu
008 220908s2019 xx |||||o 00| ||eng c
024 7 |a 10.1136/medethics-2018-105248  |2 doi 
035 |a (DE-627)1816160458 
035 |a (DE-599)KXP1816160458 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Fujita, Misao  |e VerfasserIn  |4 aut 
245 1 2 |a A rebuttal to Akabayashi and colleagues’ criticisms of the iPSC stock project 
264 1 |c 2019 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a In the October edition of the Journal of Medical Ethics, Akabayashi and colleagues state that ’to establish a heterogeneous [induced pluripotent stem cell] iPSC bank covering roughly 80% of Japan’s population…the Japanese government decided to invest JPY110 billion (US$ 1.1 billion) over 10 years in regenerative medicine research; a quarter of this was to be allocated to the iPSC stock project'. While they claim this amount of money to be an unfair distribution of state resources, we believe their assessment is based on a misunderstanding of the facts. Similarly, other criticisms by them are based on mistaken interpretations. This article is a rebuttal to the arguments that form the basis of Akabayashi and colleagues’ five criticisms by explaining their misinterpretations. 
700 1 |a Tabuchi, Keiichi  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 45(2019), 7, Seite 476-477  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnns 
773 1 8 |g volume:45  |g year:2019  |g number:7  |g pages:476-477 
856 |u https://jme.bmj.com/content/medethics/45/7/476.full.pdf  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h publisher [open (via page says license)] 
856 4 0 |u https://doi.org/10.1136/medethics-2018-105248  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://jme.bmj.com/content/45/7/476.abstract  |x Verlag  |z kostenfrei  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185614403 
LOK |0 003 DE-627 
LOK |0 004 1816160458 
LOK |0 005 20220908053737 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-03#71BCF9E006FA37BFF9231512C5BD75C455F559A5 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw